| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Divisions of Molecular Cardiovascular Biology*
and Cardiology,
Children’s Hospital and
Research Foundation, Cincinnati, Ohio; the Division of
Cardiology,
University of Cincinnati,
Cincinnati, Ohio; and the Department of Cell Biology and
Anatomy,§
University of South Carolina,
Columbia, South Carolina
Dilated cardiomyopathy is characterized by decreased contractile function and loss of myofibril organization. Previously unexplored structural and molecular events that precede and initiate dilation can now be studied in tropomodulin-overexpressing transgenic (TOT) mice exhibiting progressive dilated cardiomyopathy. Onset of dilation did not correspond to a change in transgene expression levels, which were more than threefold above normal at birth and remained elevated throughout postnatal life. Similarly, mitogen-activated protein kinase activation (p38, ERK1/ERK2, JNK1/JNK2) was not associated with dilation. In contrast, calcineurin was activated before dilation, presumably due to doubling of intracellular diastolic calcium levels in TOT cardiomyocytes. Amplitude of systolic calcium transients was greatly increased as well, demonstrating the novel and unique calcium handling profile of TOT cardiomyocytes. Loss of myofibril organization was not apparent by confocal microscopy until over 1 week after birth, although neonatal sarcomeric abnormalities were revealed by ultrastructural analysis. Rapid postnatal increases in heart:body weight ratio at 1.5 weeks were followed by two waves of mortality between 2 and 3 weeks after birth coincident with maturational stress. Ultimately, TOT pathogenesis is a compensatory response to altered sarcomeric structure driven by calcineurin activation within days after birth, making TOTs an excellent paradigm for studying the role of calcium overload in dilated cardiomyopathy.
This article has been cited by other articles:
 |
|
 |
|
  S. Siddiqi, N. Gude, T. Hosoda, J. Muraski, M. Rubio, G. Emmanuel, J. Fransioli, S. Vitale, C. Parolin, D. D'Amario, et al. Myocardial Induction of Nucleostemin in Response to Postnatal Growth and Pathological Challenge Circ. Res., July 3, 2008; 103(1): 89 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Melendez, C. Turner, H. Avraham, S. F. Steinberg, E. Schaefer, and M. A. Sussman Cardiomyocyte Apoptosis Triggered by RAFTK/pyk2 via Src Kinase Is Antagonized by Paxillin J. Biol. Chem., December 17, 2004; 279(51): 53516 - 53523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Zemljic-Harpf, S. Ponrartana, R. T. Avalos, M. C. Jordan, K. P. Roos, N. D. Dalton, V. Q. Phan, E. D. Adamson, and R. S. Ross Heterozygous Inactivation of the Vinculin Gene Predisposes to Stress-Induced Cardiomyopathy Am. J. Pathol., September 1, 2004; 165(3): 1033 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M Janczewski, M. Zahid, B. H Lemster, C. S Frye, G. Gibson, Y. Higuchi, E. G Kranias, A. M Feldman, and C. F McTiernan Phospholamban gene ablation improves calcium transients but not cardiac function in a heart failure model Cardiovasc Res, June 1, 2004; 62(3): 468 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Goldsmith, W. Carver, A. McFadden, J. G. Goldsmith, R. L. Price, M. Sussman, B. H. Lorell, G. Cooper, and T. K. Borg Integrin shedding as a mechanism of cellular adaptation during cardiac growth Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2227 - H2234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Dos Remedios, D. Chhabra, M. Kekic, I. V. Dedova, M. Tsubakihara, D. A. Berry, and N. J. Nosworthy Actin Binding Proteins: Regulation of Cytoskeletal Microfilaments Physiol Rev, April 1, 2003; 83(2): 433 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Sayen, A. B. Gustafsson, M. A. Sussman, J. D. Molkentin, and R. A. Gottlieb Calcineurin transgenic mice have mitochondrial dysfunction and elevated superoxide production Am J Physiol Cell Physiol, February 1, 2003; 284(2): C562 - C570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Melendez, S. Welch, E. Schaefer, C. S. Moravec, S. Avraham, H. Avraham, and M. A. Sussman Activation of pyk2/Related Focal Adhesion Tyrosine Kinase and Focal Adhesion Kinase in Cardiac Remodeling J. Biol. Chem., November 15, 2002; 277(47): 45203 - 45210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Frey and E. N. Olson Calsarcin-3, a Novel Skeletal Muscle-specific Member of the Calsarcin Family, Interacts with Multiple Z-disc Proteins J. Biol. Chem., April 12, 2002; 277(16): 13998 - 14004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Samarel IGF-1 Overexpression Rescues the Failing Heart Circ. Res., April 5, 2002; 90(6): 631 - 633. [Full Text] [PDF]
|
|
|
|
|
|
S. Welch, D. Plank, S. Witt, B. Glascock, E. Schaefer, S. Chimenti, A. M. Andreoli, F. Limana, A. Leri, J. Kajstura, et al. Cardiac-Specific IGF-1 Expression Attenuates Dilated Cardiomyopathy in Tropomodulin-Overexpressing Transgenic Mice Circ. Res., April 5, 2002; 90(6): 641 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. F Bueno, E. van Rooij, J. D Molkentin, P. A Doevendans, and L. J De Windt Calcineurin and hypertrophic heart disease: novel insights and remaining questions Cardiovasc Res, March 1, 2002; 53(4): 806 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Pass, J. Gao, W. K. Jones, W. B. Wead, X. Wu, J. Zhang, C. P. Baines, R. Bolli, Y.-T. Zheng, I. G. Joshua, et al. Enhanced PKCbeta II translocation and PKCbeta II-RACK1 interactions in PKCepsilon -induced heart failure: a role for RACK1 Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2500 - H2510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Frey, J. A. Richardson, and E. N. Olson Calsarcins, a novel family of sarcomeric calcineurin-binding proteins PNAS, December 8, 2000; (2000) 260501097. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Shimoyama, D. Hayashi, Y. Zou, E. Takimoto, M. Mizukami, K. Monzen, S. Kudoh, Y. Hiroi, Y. Yazaki, R. Nagai, et al. Calcineurin Inhibitor Attenuates the Development and Induces the Regression of Cardiac Hypertrophy in Rats With Salt-Sensitive Hypertension Circulation, October 17, 2000; 102(16): 1996 - 2004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Rusnak and P. Mertz Calcineurin: Form and Function Physiol Rev, October 1, 2000; 80(4): 1483 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Baudet Hypertrophy and dilation: a TOTally new story? Cardiovasc Res, April 1, 2000; 46(1): 17 - 19. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Sussman, S. Welch, A. Walker, R. Klevitsky, T. E. Hewett, S. A. Witt, T. R. Kimball, R. Price, H. W. Lim, and J. D. Molkentin Hypertrophic defect unmasked by calcineurin expression in asymptomatic tropomodulin overexpressing transgenic mice Cardiovasc Res, April 1, 2000; 46(1): 90 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Lim, L. New, J. Han, and J. D. Molkentin Calcineurin Enhances MAPK Phosphatase-1 Expression and p38 MAPK Inactivation in Cardiac Myocytes J. Biol. Chem., May 4, 2001; 276(19): 15913 - 15919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Frey, J. A. Richardson, and E. N. Olson Calsarcins, a novel family of sarcomeric calcineurin-binding proteins PNAS, December 19, 2000; 97(26): 14632 - 14637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Camper-Kirby, S. Welch, A. Walker, I. Shiraishi, K. D. R. Setchell, E. Schaefer, J. Kajstura, P. Anversa, and M. A. Sussman Myocardial Akt Activation and Gender : Increased Nuclear Activity in Females Versus Males Circ. Res., May 25, 2001; 88(10): 1020 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Welch, D. Plank, S. Witt, B. Glascock, E. Schaefer, S. Chimenti, A. M. Andreoli, F. Limana, A. Leri, J. Kajstura, et al. Cardiac-Specific IGF-1 Expression Attenuates Dilated Cardiomyopathy in Tropomodulin-Overexpressing Transgenic Mice Circ. Res., April 5, 2002; 90(6): 641 - 648. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
